Home › Targets › PAH

PAH (2 companies · 2 programs)

Companies with an active program directed at PAH.

AGIOS PHARMACEUTICALS, INC. AGIO

AG-181 — Phenylketonuria Phase 1

Beam Therapeutics Inc. BEAM

BEAM-304 — Phenylketonuria Phase 1